What You Should Know:
– Caris Life Sciences® (Caris), a pioneer in precision medicine and next-generation AI TechBio innovation, announced a transformative collaboration with Ontada®, a leading organization in oncology real-world evidence, clinical education, and point-of-care technologies.
– …
Continue Reading
What You Should Know:
– NVIDIA announced widespread adoption of its open-source BioNeMo™ Framework by pharmaceutical companies, techbio innovators, and AI researchers to accelerate drug discovery and molecule design.
– The framework provides a powerful suite…
Continue Reading
What You Should Know:
Caris Life Sciences®(Caris), the leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionise healthcare and improve the human condition using molecular science…
Continue Reading
What You Should Know:
– Unnatural Products, Inc. (UNP), a biotech company harnessing the power of AI and chemistry to design the next generation of targeted therapeutics, has secured $32M in Series A funding.
– Led…
Continue Reading
What You Should Know:
– ARTIS Ventures, a pioneer in this “TechBio” revolution, announces the closing of its second fund, TechBio II, with $200M focused on healthcare and biology innovation.
– The fund aims to support…
Continue Reading
by Jasmine Pennic 06/12/2023 Leave a Comment
What You Should Know:
Range Biotechnologies (Range Bio) announced $5.2M in seed funding, led by TechBio-focused ARTIS Ventures with participation from Pear VC, Page One Ventures, Civilization Ventures, Pillar,…
Continue Reading
The following is a guest article by Hakim Yadi, PhD OBE, Co-Founder and CEO at Closed Loop Medicine
Healthcare has historically taken a ‘one size fits all’ approach, which misses the ability to treat all…
